Navigation Links
Leeds researchers reshape the future of drug discovery
Date:11/18/2008

using a complex combination of different reactions.

The team has deliberately chosen to prepare molecules with structural features that are similar to those found in natural products: "For example we know that putting oxygen atoms on every other carbon atom is something that frequently occurs in nature and has evolved for a useful purpose" says Professor Nelson. "We're not aiming to improve on existing natural products or drugs - we want to create molecules with functions that nature's not got round to making yet, or something that would only evolve naturally with new selection pressures that would make it beneficial for the organism."

Work has already begun across campus to screen the molecules, which are already yielding "promising" results. The team are considering patenting molecules with novel biological functions.


'/>"/>

Contact: Professor Adam Nelson
a.s.nelson@leeds.ac.uk
44-011-334-36502
University of Leeds
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Leeds medics solve an ancient riddle -- and offer new tool for diagnosis
2. UNC researchers find clue to stopping breast-cancer metastasis
3. U of U researchers to use patients own stem cells to treat heart failure
4. Researchers identify toehold for HIVs assault on brain
5. Researchers Tackle CLL, Diabetes and Trauma-Hemorrhage
6. Researchers Use New Method to Control Bleeding in Hemophilia
7. Stem cells with potential to regenerate injured liver tissue identified by Penn researchers
8. Protein can nurture or devastate brain cells, depending on its friends, researchers find
9. Researchers find stem cells from monkey teeth can stimulate growth and generation of brain cells
10. Battling Bacteria in the Blood: U-M Researchers Tackle Deadly Infections
11. Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 2Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 3Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 4Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 3Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 2Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 3Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 4Health News:Life Science And Medical Device Software Engineering Consulting Firm Full Spectrum Software Announces 12 New Contract Wins In 2009 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 3
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3HealthFitness Announces Third Quarter 2009 Financial Results 60712 1HealthFitness Announces Third Quarter 2009 Financial Results 60712 2HealthFitness Announces Third Quarter 2009 Financial Results 60712 3HealthFitness Announces Third Quarter 2009 Financial Results 60712 4HealthFitness Announces Third Quarter 2009 Financial Results 60712 5HealthFitness Announces Third Quarter 2009 Financial Results 60712 6HealthFitness Announces Third Quarter 2009 Financial Results 60712 7HealthFitness Announces Third Quarter 2009 Financial Results 60712 8HealthFitness Announces Third Quarter 2009 Financial Results 60712 9HealthFitness Announces Third Quarter 2009 Financial Results 60712 10HealthFitness Announces Third Quarter 2009 Financial Results 60712 11Regence Foundation Announces Largest Set of Quarterly Grant Awards in Its History 60707 1Regence Foundation Announces Largest Set of Quarterly Grant Awards in Its History 60707 2Regence Foundation Announces Largest Set of Quarterly Grant Awards in Its History 60707 3Zyngenia Inc Raises 2410 Million in Series A Funding 14724 1Zyngenia Inc Raises 2410 Million in Series A Funding 14724 2Zyngenia Inc Raises 2410 Million in Series A Funding 14724 3Zyngenia Inc Raises 2410 Million in Series A Funding 14724 4